Method | Test | Sensitivity (95% CI) | Specificity (95% CI) | PPV (95% CI) | NPV (95%CI) | Kappa (k) |
---|---|---|---|---|---|---|
Paracheck | Pure and mixed Pf | 97.1 (93.3-99) | 96.4 (92.4-98.7) | 96.5 (92.5-98.7) | 97 (93.2-99) | 0.94 |
Falcivax | Pure and mixed Pf | 97.6 (94.1-99.4) | 95.8 (91.6-98.3) | 96 (91.8-98.4) | 97.6 (93.9-99.3) | 0.94 |
Onsite Pf | Pure and mixed Pf | 94.1 (89.4-97.1) | 97.6 (94-99.3) | 97.6 (93.9-99.3) | 94.3 (89.7-97.2) | 0.92 |
Onsite Pf/Pv | Pure and mixed Pf | 92.9 (88-96.3) | 98.8 (95.8-99.9) | 98.8 (95.6-99.8) | 93.3 (88.5-96.5) | 0.92 |
Microscopy | Pure and mixed Pf | 97.6 (94.1-99.4) | 97 (93.2-99) | 97.1 (93.3-99) | 97.6 (94-99.3) | 0.95 |
Falcivax | Pure and mixed Pv | 76.9 (56.4-91) | 100 (98.8-100) | 100 (83.2-100) | 98.1 (95.9-99.3) | 0.86 |
Onsite Pf/Pv | Pure and mixed Pv | 76.9 (56.4-91) | 99 (97.2-99.8) | 87 (66.4-97.2) | 98.1 (95.9-99.3) | 0.80 |
Microscopy | Pure and mixed Pv | 76.9 (56.4-91) | 99.7 (98.2-100) | 95.2 (76.2-99.9) | 98.1 (95.8-99.3) | 0.84 |